3D model

3D-Bioprinted Cancer Model to Test Anticancer Drugs

April 19, 2019

Researchers from both the University of Minnesota College of Science and Engineering and Medical School have created a new, dynamic 3D bioprinted tumor model that will help researchers screen anticancer drugs and study the spread of cancer.

The new model should help a current major pitfall of translating drugs from the lab bench to a viable treatment due to the differences of a 2D petri dish versus the 3D human body.

"I think our model has the key components to push the boundaries of in vitro cancer research,” said co-senior author Angela Panoskaltsis-Mortari, PhD, Department of Pediatrics.

The results of the studypublished in Advanced Materials, found that the 3D-bioprinted model shows drugs take more time to kill fewer cells than previous studies have shown, however, the results likely show a more accurate representation.

Other News

OACA interns
Colton Cannon and Claire Knutson are working to observe how the recently implemented tiered huddle system is operating.
Two minds together
This marks the partnership's 18th year of spearheading new scientific ideas to improve the health of Minnesotans.
A Look Back at 2021
CTSI created a research infrastructure to improve, streamline, and facilitate the process of bench to bedside.